rs1555690804
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_004218.4(RAB11B):c.202G>A(p.Ala68Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A68S) has been classified as Uncertain significance.
Frequency
Consequence
NM_004218.4 missense
Scores
Clinical Significance
Conservation
Publications
- neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matterInheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD2 exomes AF: 0.00 AC: 0AN: 250980 AF XY: 0.00
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter Pathogenic:3
This variant is interpreted as Likely Pathogenic, for Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter. The following ACMG Tag(s) were applied: PM6 => Assumed de novo, but without confirmation of paternity and maternity (https://www.ncbi.nlm.nih.gov/pubmed/29106825). PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PP3 => Multiple lines of computational evidence support a deleterious effect on the gene or gene product. PP2 => Missense variant in a gene that has a low rate of benign missense variation and in which missense variants are a common mechanism of disease. -
- -
PS4, PM2, PM6, PP3, PP5 -
not provided Pathogenic:2
An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects RAB11B function (PMID: 29106825). For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with RAB11B-related neurodevelopmental disorder (PMID: 29106825). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 453255). This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 68 of the RAB11B protein (p.Ala68Thr). -
Published functional studies demonstrate a damaging effect on the protein, although gold-standard functional assays have not been established for the RAB11B gene (PMID: 29106825); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34740920, 33057194, 35982159, 31785789, 33644862, 29106825, 37734130) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at